Chemed Corporation (CHE) Tops Q1 EPS by 36c, Maintains Guidance

Chemed Corporation (NYSE: CHE) reported Q1 EPS of $2.72, $0.36 better than the analyst estimate of $2.36. Revenue for the quarter came in at $439.2 million versus the consensus estimate of $419.34 million.

Guidance for 2018

The first-quarter 2018 operating results did exceed Chemed management’s expectations. The Company has reiterated the earnings guidance issued in February 2018 and anticipates providing updated guidance for the second half of 2018 when it reports second-quarter results.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c